← All companies

ZTS

Zoetis Inc.

ZTS NYSE Pharmaceutical Preparations EDGAR ↗

$77.10

+1.07 +1.41%

Key statistics

from XBRL data in SEC filings

Market cap

$32.3B

Revenue (TTM)

$9.53B

Net income (TTM)

$2.67B

EPS (TTM)

$6.10

P/E ratio

12.6

Dividend yield

2.67%

Free cash flow

$2.28B

Cash

$1.94B

Total assets

$15.2B

Gross margin

—

52-week range

$71.47 – $160.48

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results May 22, 2026 8-K Regulation FD disclosure May 20, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 12, 2026 8-K Results of operations (earnings release) Feb 12, 2026 8-K Regulation FD disclosure Feb 5, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Dec 18, 2025 8-K Regulation FD disclosure Dec 11, 2025 8-K Other events Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Director or officer change; Regulation FD disclosure Oct 28, 2025 8-K Regulation FD disclosure Oct 9, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Aug 27, 2025 8-K Other events Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Director or officer change; Shareholder vote results May 22, 2025 8-K Regulation FD disclosure May 21, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 13, 2025 8-K Results of operations (earnings release) Feb 13, 2025 8-K Regulation FD disclosure Feb 6, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure Dec 12, 2024 8-K Change in control; Other events Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release) Nov 4, 2024 8-K Regulation FD disclosure Oct 10, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Regulation FD disclosure Aug 1, 2024 8-K Director or officer change May 24, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results May 23, 2024 8-K Regulation FD disclosure May 22, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Director or officer change Apr 16, 2024